Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sherrolyn G. Weed"'
Autor:
Efrain Reisin, Sherrolyn G. Weed
Publikováno v:
Journal of Hypertension. 10:489-493
OBJECTIVE We attempted to determine a valid pharmacological approach for the control of high blood pressure in obese hypertensive patients using two antihypertensive agents with different pharmacological actions. DESIGN Thirty-two obese hypertensive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c90955045ffd806ff93543ed4adefe
https://doi.org/10.1097/00004872-199205000-00013
https://doi.org/10.1097/00004872-199205000-00013
Autor:
Edward A. Panacek, Mark A. Munger, Edward M. Bednarczyk, William F. Rutherford, Francisco M. Gonzalez, George Emmanuel, A. I. Hakki, Lynn Anderson, Sherrolyn G. Weed, Jeffrey A. Green
Publikováno v:
Critical Care Medicine. 18:502-504
To evaluate the acute BP response to iv fenoldopam mesylate (FNP), 14 patients with severe hypertension (diastolic BP 120 to 170 mm Hg) were studied in an open-label trial. Initial infusion rate of FNP was 0.1 microgram/kg.min. Titration to diastolic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8059852f3854cce9c7a0cbefaf26b0
https://doi.org/10.1097/00003246-199005000-00008
https://doi.org/10.1097/00003246-199005000-00008
Autor:
Mark A. Munger, William F. Rutherford, Francisco M. Gonzalez, Edward A. Panacek, William B. White, Andrew R. Nara, Jeffrey A. Green, Sherrolyn G. Weed, Edward M. Bednarczyk
Publikováno v:
The American journal of cardiology. 63(13)
Fenoldopam mesylate (SK&F 82526J) (FNP) is a specific postsynaptic dopamine-1 receptor agonist,1 with weak α2-antagonistic properties.2 The agent is devoid of dopamine-2, α-1 or β-adrenergic activity.3 Fenoldopam functions as an arteriolar vasodil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a23dde6ead39fd215afd68a66768bb9
https://pubmed.ncbi.nlm.nih.gov/2564726
https://pubmed.ncbi.nlm.nih.gov/2564726